MARKET NEWS AND UPDATES.
Get notified for Latest News and Market Alerts.
Get notified for Latest News and Market Alerts.
×
| Fund Name | : | SBI Mutual Fund |
| Scheme Name | : | SBI Healthcare Opportunities Fund Growth |
| AMC | : | SBI Mutual Fund |
| Type | : | Open |
| Category | : | Equity - Pharma |
| Launch Date | : | 04-Jun-99 |
| Fund Manager | : | Tanmaya Desai |
| Net Assets (Rs. cr) | : | 1942.51 |
| 1w | 1m | 3m | 6m | 1y | 3y | 5y | Since INC | |
| Scheme Returns | [4.03] | [2.01] | [1.09] | [7.01] | 9.66 | 22.09 | 10.81 | 14.41 |
| Category Avg | [4.06] | [2.17] | [3.29] | [6.20] | 12.41 | 25.95 | 14.54 | 18.11 |
| Category Best | [3.49] | [0.41] | [0.83] | [1.86] | 21.71 | 31.54 | 17.81 | 30.31 |
| Category Worst | [4.91] | [3.50] | [6.52] | [10.05] | 6.14 | 22.09 | 10.81 | [2.66] |
| No Data Found |
| Dividends | Bonus | |
| Ratio | NA | NA |
| Date | NA | NA |
| Min. Investment(Rs.) | : | 5000 |
| Increm.Investment(Rs.) | : | 1000 |
| In | |
| Name of the Company | No of shares |
| Medplus Health | 911178 |
| Out | |
| Name of the Company | No of shares |
| No Data Found | |
| Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) |
| Equity & Equity related Investments | |||||
| Equity | Sun Pharma.Inds. | Pharmaceuticals | 12.19 | 2,800,000.00 | 236.80 |
| Equity | Dr Reddy's Labs | Pharmaceuticals | 9.85 | 390,000.00 | 191.37 |
| Equity | Cipla | Pharmaceuticals | 8.75 | 1,800,000.00 | 169.94 |
| Equity | Divi's Lab. | Pharmaceuticals | 8.67 | 360,000.00 | 168.42 |
| Equity | Max Healthcare | Healthcare Services | 7.30 | 3,200,000.00 | 141.73 |
| Equity | Apollo Hospitals | Healthcare Services | 6.19 | 240,000.00 | 120.32 |
| Equity | Aurobindo Pharma | Pharmaceuticals | 4.99 | 1,320,000.00 | 96.93 |
| Equity | Lupin | Pharmaceuticals | 4.89 | 1,000,000.00 | 95.08 |
| Equity | Medplus Health | Retailing | 4.78 | 911,178.00 | 92.92 |
| Equity | Alkem Lab | Pharmaceuticals | 3.36 | 180,000.00 | 65.23 |
| Equity | Torrent Pharma. | Pharmaceuticals | 3.04 | 180,000.00 | 59.01 |
| Equity | Fortis Health. | Healthcare Services | 2.75 | 1,800,000.00 | 53.51 |
| Equity | J B Chem & Pharm | Pharmaceuticals | 2.75 | 300,000.00 | 53.39 |
| Equity | Narayana Hrudaya | Healthcare Services | 2.63 | 800,000.00 | 51.16 |
| Equity | Gland Pharma | Pharmaceuticals | 2.49 | 125,000.00 | 48.31 |
| Equity | Abbott India | Pharmaceuticals | 2.41 | 24,000.00 | 46.77 |
| Equity | Ajanta Pharma | Pharmaceuticals | 1.84 | 160,000.00 | 35.77 |
| Equity | Ami Organics | Pharmaceuticals | 1.62 | 295,080.00 | 31.53 |
| Equity | Gufic BioScience | Pharmaceuticals | 1.35 | 1,103,859.00 | 26.23 |
| Equity | Krsnaa Diagnost. | Healthcare Services | 1.21 | 320,000.00 | 23.60 |
| Equity | Solara Active | Pharmaceuticals | 1.03 | 197,004.00 | 20.08 |
| Equity | Strides Pharma | Pharmaceuticals | 0.83 | 360,000.00 | 16.09 |
| Equity | Vijaya Diagnost. | Healthcare Services | 0.48 | 160,000.00 | 9.32 |
| Equity | Natco Pharma | Pharmaceuticals | 0.47 | 100,000.00 | 9.05 |
| Equity | Sequent Scien. | Pharmaceuticals | 0.42 | 510,265.00 | 8.21 |
| Debt Investments | |||||
| Corporate Debts | Shreno Ltd | -/- | 0.35 | 4,000,000.00 | 6.87 |
| Cash & Cash Equivalent | |||||
| Reverse Repo | TREPS | -/- | 3.25 | 0.00 | 63.13 |
| Net CA & Others | Net CA & Others | -/- | 0.11 | 0.00 | 1.77 |
| Fund House | : SBI Mutual Fund |
| Incorporation Date | : 07-Feb-1992 |
| Total Assets Managed (Cr.) | : 628,766.10 |
| Trustee/s | : SBI Mutual Fund Trustee C |
| Chairman | : N/A |
| CEO / MD | : Mr. Vinay M. Tonse |
| CIO | : N/A |
| President | : N/A |
| Director/s | : Om Prakash Gahrotra |
| Compliance Officer/s | : N/A |
| Investor Service Officer/s | : N/A |
| Fund Manager/s | : Tanmaya Desai |
| Auditors | : N/A |
| Registered Office | : 9th Floor,Crescenzo, C-39&39, G Block, Bandra kurla complex, Bandra (east), Mumbai-400 051. |
| Contact Nos | : 022-61793000 |
| Fax | : 022-67425687 |
| : partnerforlife@sbimf.com | |
| Website | : www.sbimf.com |
Growth will come back and people will take time to adjust, which is why we will spend the next 1-1.5 years in a consolidation phase....
Delivery Brokerage for Lifetime
Per order for Intraday, F&O, Currency & Commodity
